Advertisement PharmaCenter to begin marketing EastGate's nutraceutical products - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PharmaCenter to begin marketing EastGate’s nutraceutical products

US company EastGate Biotech has selected Hungary-based PharmaCenter to market E-drops, one of the company's nutraceutical products in Slovakia and Czech Republic.

EastGate is aimed at using drug delivery innovations in the development of improved new formulations and alternative dosage forms of existing biologically active molecules.

E-drops has been successfully registered by PharmaCenter with the local health authority in Slovakia and placed an initial sample order for the product which is the company’s natural and herbal alternative.

The product assists to rid the body of UTI infections painlessly and effectively without side effects of synthetic drugs.

Initially, the sample order will be used for test marketing and launch in Slovakia before entering into the other respective markets.

EastGate CEO Anna Gluskin said: "We are pleased to have PharmaCenter open up the market for our nutraceutical products in other countries.

"It is important to extend our reach to as many markets as possible to not only increase sales which enrich the bottom line, but also to gain exposure for our sub-micron delivery platform technology."

PharmaCenter, which provides full range of marketing and sales services including market access support, mainly focuses on the business of selling new oncology, urology, onco-urology, OB-GYN and orphan drugs.